Trial intelligence / Profile preview

Immunogenicity and Safety of TdaP and DTaP Vaccines in Healthy Children

TCTR20190201001Phase 2Completed

Sponsor
BioNet
Start
Jul 2019
Countries
1
01

Overview

A Phase 2 trial of diphtheria, tetanus, and acellular pertussis vaccine in pertussis, diphtheria, Tetanus, sponsored by BioNet. Started Jul 2019; status: completed.

02

Drugs

diphtheria, tetanus, and acellular pertussis vaccine
03

Conditions

pertussisdiphtheriaTetanus

Beyond the preview

Go deeper on TCTR20190201001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190201001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call